Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health, where she provides consultations to individuals and families at risk for hereditary breast cancer.
Cristina earned a B.S. in biology at Ursinus College. Thereafter, she was an associate scientist for two years at GlaxoSmithKline in the Gene Expression and Protein Biochemistry Department. She completed her thesis with the Cancer Risk Assessment Program at Lankenau Medical Center as part of her M.S. in genetic counseling with Arcadia University, where she graduated in 2009. Her thesis was titled "Medical Management Decision Making Following Uninformative BRCA1/BRCA2 Genetic Test Result Disclosure."
In 2011, she participated in an Intensive Course in Cancer Risk Assessment through the City of Hope located near Los Angeles, California.
In addition to counseling patients, Cristina participates in Main Line Health's multidisciplinary breast conferences and routinely teaches fellows, residents, and medical students. She also assists with several research projects, including a recent study looking at multi-gene panels in BRCA1/BRCA2-positive families.
"I am honored to be on the Professional Advisory Board of Breastcancer.org. My primary goals are to help families understand if they may be at risk for hereditary breast cancer and to increase awareness for these families on how genetic testing may be helpful in both the prevention and treatment of breast cancer."
Can we help guide you?
Create a profile for better recommendations
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
What Is Breast Implant Illness?
Breast implant illness (BII) is a term that some women and doctors use to refer to a wide range...